SaliCov is an innovative test for antigen detection in saliva that does not require professional personnel or laboratory equipment.
Employees: 11-50
Total raised: $8M
Founded date: 2016
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.04.2022 | - | $8M | - |
Mentions in press and media 2
| Date | Title | Description |
| 28.05.2024 | Sheba Medical Center & Salignostics to Develop Saliva Test for Early Oral Cancer Detection | What You Should Know: – Jerusalem-based Salignostics, a company specializing in rapid tests using saliva samples, has joined forces with ARC Innovation, the innovation arm of Sheba Medical Center, in a groundbreaking initiative. – The strat... |
| 14.04.2022 | Salignostics Raises $8M for Rapid Saliva-Based Test Kits That Detect Pregnancy, COVID-19, Cardiac Risk, and Malaria | What You Should Know: – Israeli startup Salignostics, the developer and provider of rapid saliva-based tests for early pregnancy detection, as well as COVID-19, cardiac risk, malaria, and other diseases, has closed an $8 million Series A fu... |